PEPFAR
Latest
PEPFAR HIV Program Gets Yearlong Lifeline: What's Next?
PEPFAR's former chief of staff describes why its latest reauthorization still spells uncertainty for the program
Retreat from Global HIV Fight Puts U.S. Health At Risk
With news that HIV/AIDS funding is stalled, Congress should remember the AIDS epidemic and commit to funding PEPFAR
Rethinking HIV in an Aging Society
Central to supporting elderly communities is providing people living with HIV better integrated primary care
Africa's Crisis of Trust
How vaccine inequities and geopolitical shifts have eroded Africa’s trust in U.S. aid
PEPFAR, Politics, and PSI: An Implementer’s Perspective
The bipartisan importance of PEPFAR
Inside the New Bureau of Global Health Security and Diplomacy
An interview with Ambassador-at-Large John Nkengasong
PEPFAR Reauthorization on the Horizon
What could happen if the United States’ signature initiative on global health is not reauthorized
In South Africa, Much More Than an Investment in HIV
Quarraisha Abdool Karim, UNAIDS special ambassador for adolescents and HIV, on "building one house" for health
PEPFAR in a Global Democratic Recession
At age twenty, PEPFAR's continued success depends on weathering an illiberal wave worldwide
PEPFAR Meets Climate Change
Another president's emergency plan for another global health crisis
PEPFAR's Twentieth Anniversary Might Be Its Last
Proposed changes to the mold-breaking program could break it for good
Why Global Health Remains Bipartisan
It has proven to be "a good investment with astonishing results in saving lives"
The Global Fund, PEPFAR, and U.S. Foreign Policy
COVID-19 raises questions about these global health programs and U.S. national interests
Tackling Tuberculosis with Strategic Health Diplomacy
Cutting drug prices for tuberculosis holds diplomatic, humanitarian, and economic promise